Estimated Prevalence of Opioid Dependence in Scotland
Data and Resources
-
Estimated Prevalence of Opioid Dependence in ...CSV
This file contains estimates of the prevalence of opioid dependence in...
Additional Info
| Field | Nilai |
|---|---|
| Sumber | Scottish Public Health Drug Linkage Programme |
| Pembuat | PHS Drugs Team |
| Last Updated | March 19, 2024, 09:52 (GMT) |
| Dibuat | March 14, 2024, 09:31 (GMT) |
| Contact Address | Public Health Scotland, Gyle Square, 1 South Gyle Crescent, Edinburgh, EH12 9EB |
| Subject | Health & Social Care, Substance Use |
| Frequency | Annual |
| Time frame of data and timeliness | The timeframe for the data used in this publication is financial years 2009/10 to 2019/20. |
| Coverage | The timeframe for the data used in this publication is financial years 2009/10 to 2019/20. |
| Completeness | The estimates described are derived from a complex statistical modelling process. While the methodology and results have been subject to extensive peer review, the estimates may be subject to change as new data (additional years or event types) are incorporated within the model. |
| Accuracy | Data from the Scottish Public Health Drug Linkage Programme (SPHDLP) was used in the modelling. The SPHDLP involves combining existing national datasets to construct a comprehensive cohort of the Scottish population of people who use drugs, and covers the period 01/04/2009 onwards. Data are linked on Community Health Index (CHI) number, which is a unique patient identifier used throughout health and care services associated with NHS Scotland. The availability of verified CHI numbers for individual data sources (apart from Prescribing Information System) was generally very high, enabling robust linkage between datasets using historic or current patient identifiers. Consequently, the SPHDLP linkage has a high degree of reliability, with only a small probability of health activity or harm data being assigned to a person incorrectly. |
| Continuity of data | SPHDLP data definitions were consistent across the timeframe for the data used in this publication. Due to methodological differences in calculating prevalence estimates, comparisons with the results from previous Prevalence of Problem Drug Use in Scotland reports should be done with caution. |
| Concepts and definitions | Estimated number and prevalence of people aged 15-64 with opioid dependence in Scotland, for financial years 2014/15 to 2019/20. Prevalence Prevalence of a specific characteristic, such as opioid dependence, is defined as the total number of individuals/cases with the characteristic as a percentage of the general population. Opioid Agonist Therapy (OAT) Opioid Agonist Therapy (OAT), such as methadone and buprenorphine, is treatment prescribed to prevent withdrawal and reduce cravings for opioid drugs. This is equivalent to the term Opioid Substitution Therapy (OST) used in other PHS publications. OAT exposure OAT exposure or coverage describes the percentage of people with opioid dependence receiving OAT. In this report, we use the term 'OAT exposure' per financial year to refer specifically to the percentage who received at least one OAT prescription during the year. Note that receipt of at least one OAT prescription in a year does not necessarily imply continuous OAT during the year. Observed population or baseline cohort Throughout this report, the terms 'observed population' and 'baseline cohort' are used interchangeably to refer to all people who received at least one OAT prescription during the year or during the four preceding years. In this report and analysis, it is assumed that all people in the baseline cohort are opioid dependent. Unobserved population In this report, 'unobserved population' is used to refer to people with opioid dependence who were not among the baseline cohort. The size of the unobserved population (and therefore of the total population) is estimated from the model. Total population 'Total population' is used in this report to refer to the total number of people with opioid dependence. By definition, it is equal to the size of the observed population plus the size of the unobserved population. |
| Disclosure | PHS Statistical Disclosure Control Protocol has been applied. |
| Revision statement | None |
| Official statistics designation | Official Statistics in Development |
| Relevance and key uses of the statistics | This data provides information to enable calculation of the estimated number and prevalence of people aged 15-64 with opioid dependence in Scotland for financial years 2014/15 to 2019/20. Information on the size and demographics of this population is used by a range of national and local stakeholders for strategic planning purposes, and by statistics producers and researchers for understanding the population context in which public health interventions are being delivered. |
| Format | CSV |
| Language | English |
| Links |
comments powered by Disqus